Related Experiment Videos
[Lymphatic involvement predominating and revealing prostatic carcinoma].
R Llarena Ibarguren1, J A Zabala Egurrola, A Arruza Echevarría
1Servicio de Urología, Hospital de Cruces, Vizcaya, España.
Archivos Espanoles De Urologia
|June 1, 1992
Summary
Prostate cancer rarely spreads to lymph nodes, but when it does, it presents as lymphadenopathy. Diagnosis requires histology and immunoperoxidase staining for prostate cancer detection. Prognosis is poor, with survival under five years.
Area of Science:
- Oncology
- Pathology
- Urology
Background:
- Prostatic carcinoma commonly metastasizes to the lymphatic system.
- Lymphadenopathy as an initial presentation of prostate cancer is uncommon.
- Metastatic prostate cancer can mimic lymphoreticular malignancies.
Observation:
- Three cases of prostatic carcinoma presenting as lymphadenopathy are described.
- Two cases presented with retroperitoneal masses.
- One case presented with left lateral cervical lymphadenopathy.
Findings:
- Diagnosis relies on histological examination.
- Immunoperoxidase staining for acid phosphatase and prostate-specific antigen is crucial for identifying occult prostate tumors.
- Prostate cancer presenting as lymphadenopathy has a poor prognosis, with survival typically less than five years.
Implications:
- Early detection of prostate cancer metastasis through lymph node biopsy is critical.
- Histochemical markers aid in diagnosing unusual presentations of prostate cancer.
- Palliative treatment and hormone therapy may offer temporary remission but do not alter the overall poor prognosis.